BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24571424)

  • 1. Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II-III rectal cancer: A population-based study.
    Ke TW; Liao YM; Chiang HC; Chang SC; Wang PH; Chen YY; Chen WT; Chien CR
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e234-40. PubMed ID: 24571424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis.
    Li CC; Liang JA; Chen WT; Chien CR
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e197-e203. PubMed ID: 31250970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Intensity-Modulated Radiotherapy for Rectal Cancer Patients Treated With Neoadjuvant Concurrent Chemoradiotherapy: A Population-based Propensity Score-matched Analysis.
    Li CC; Liang JA; Chung CY; Chen WT; Chien CR
    Anticancer Res; 2019 Mar; 39(3):1479-1484. PubMed ID: 30842185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Karagkounis G; Thai L; Mace AG; Wiland H; Pai RK; Steele SR; Church JM; Kalady MF
    Ann Surg; 2019 Jun; 269(6):1117-1123. PubMed ID: 31082910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the interval between neoadjuvant concurrent chemoradiotherapy and esophagectomy in the modern era: a population-based propensity-score-matched retrospective cohort study in Asia.
    Kuo YH; Chien YW; Chen PR; Feng CL; Li CC; Chien CR
    World J Surg Oncol; 2019 Dec; 17(1):222. PubMed ID: 31856840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of Total Neoadjuvant Therapy Followed by Radical Resection Versus Conventional Therapy for Locally Advanced Rectal Cancer.
    Wright ME; Beaty JS; Thorson AG; Rojas R; Ternent CA
    Dis Colon Rectum; 2019 May; 62(5):568-578. PubMed ID: 30964794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of lymph node retrieval in locoregional rectal cancer treated with chemoradiotherapy: a California Cancer Registry Study.
    Gill A; Brunson A; Lara P; Khatri V; Semrad TJ
    Eur J Surg Oncol; 2015 May; 41(5):647-52. PubMed ID: 25800934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Impacts of Preoperative Radiotherapy and Chemoradiotherapy on Oncological Outcomes in Patients with Stages II and III Lower Rectal Cancer: A Propensity Score Analysis.
    Takiyama H; Kawai K; Ishihara S; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dig Surg; 2018; 35(3):212-219. PubMed ID: 28637039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Mitomycin-C in neoadjuvant concurrent chemoradiotherapy for rectal cancer.
    Wang LW; Liu YS; Jiang JK
    J Chin Med Assoc; 2022 Dec; 85(12):1120-1125. PubMed ID: 36194168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant Chemotherapy With/Without Radiotherapy for Locally Advanced Rectal Cancer: A Nationwide Retrospective Cohort Study.
    Ke TW; Chang SC; Liao YM; Lin CH; Chen WT; Liang JA; Li CC; Chien CR
    Anticancer Res; 2023 Dec; 43(12):5713-5722. PubMed ID: 38030192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional Probability of Survival After Neoadjuvant Chemoradiation and Proctectomy for Rectal Cancer: What Matters and When.
    Karagkounis G; Liska D; Kalady MF
    Dis Colon Rectum; 2019 Jan; 62(1):33-39. PubMed ID: 30451761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy after neoadjuvant chemoradiation and proctectomy improves survival irrespective of pathologic response in rectal adenocarcinoma: a population-based cohort study.
    Naffouje SA; Liu YJ; Kamarajah SK; Salti GI; Dahdaleh F
    Int J Colorectal Dis; 2022 Oct; 37(10):2137-2148. PubMed ID: 36048196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of neoadjuvant concurrent chemoradiotherapy versus esophagectomy for locally advanced esophageal squamous cell carcinoma: A population-based matched case-control study.
    Lin CY; Fang HY; Feng CL; Li CC; Chien CR
    Thorac Cancer; 2016 Apr; 7(3):288-95. PubMed ID: 27148413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Is the Utility of Restaging Imaging for Patients With Clinical Stage II/III Rectal Cancer After Completion of Neoadjuvant Chemoradiation and Prior to Proctectomy?
    Hendrick LE; Buckner JD; Guerrero WM; Shibata D; Hinkle NM; Monroe JJ; Glazer ES; Deneve JL; Dickson PV
    Am Surg; 2021 Feb; 87(2):242-247. PubMed ID: 32927959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic Neoadjuvant Radiotherapy for Stage M1a Rectal Adenocarcinoma Patients Treated With Systemic Therapy Followed by Proctectomy and Metastasectomy: A Nationwide Retrospective Cohort Study.
    Ke TW; Chang SC; Chen HC; Wang HM; Chen WT; Chen YC; Hsieh MH; Tsai YY; Huang CW; Liao YM; Lin CH; Huang CL; Chen LC; Chien CR
    Anticancer Res; 2023 Apr; 43(4):1843-1851. PubMed ID: 36974811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.
    Kuan FC; Lai CH; Ku HY; Wu CF; Hsieh MC; Liu TW; Yeh CY; Lee KD
    Int J Cancer; 2017 Apr; 140(7):1662-1669. PubMed ID: 27935051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.